What do Nigerians think about the newly approved malaria vaccine? 

On April 17, the National Agency for Food and Drug Administration and Control (NAFDAC) approved the R21 Malaria vaccine, making Nigeria the second country to grant approval after Ghana. Given the growing concerns around vaccine hesitancy globally, especially around new vaccines, it is important to empirically assess the willingness of Nigerians to receive the newly approved vaccines and start to put measures in place to lower vaccine hesitancy.

Research Connect Nigeria surveyed a panel of Nigerians from April 28 - 30 on their response to the newly approved Malaria vaccine. We asked Nigerians questions on

• their awareness of the newly approved malaria vaccine

• the willingness to receive the vaccine for themselves 

• willingness to receive the vaccine for children

• their greatest concern about the vaccine

• trusted information source for the vaccine

• what they have heard about the vaccine that could influence their decisions to receive or decline the vaccine

See responses to these questions by the side. These findings have implications for policy and practice. For more information about this data, follow us on social media, contact info@researchconnectng.com. Explore www.researchconnectng.com for more about Research Connect Nigeria.